Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Shanghai Pharmaceuticals Holding Co. Ltd. (S1R)
Market Open
11 Aug, 08:31
XFRA
All
(5)
DE
(3)
HK
(1)
US
(1)
HKEX
Primary
XSTU
XFRA
XDUS
OTC PINK
1.
25
0
0%
4.45B
Market Cap
-
P/E Ratio
0.06%
Div Yield
11
Volume
0
Eps
1.25
Previous Close
Watching
Watch
Add Transaction
Day Range
1.25
1.28
Year Range
1.16
1.42
Want to track
S1R
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Shanghai Pharmaceuticals Holding Co. Ltd. (S1R) Statistics
Valuation metrics
Market Cap
4.45B
Enterprise value
4.09B
Trailing P/E (ttm)
6.42
Forward P/E
-
PEG ratio
-
Price/Sales (ttm)
0.02
Price/Book (mrq)
0.48
Enterprise Value/Revenue
0.12
Enterprise Value/EBITDA
3.45
Overview
Shares outstanding
3.71B
Float
1.56B
Shares short
-
% Held by insiders
0.34%
% Held by institutions
0.14%
Average volume (10 days)
5
Average volume (90 days)
91
Price summary
52-Week low
1.16
52-Week high
1.42
Beta
0.33
50-Day moving average
1.25
200-Day moving average
1.29
Dividends and splits
Forward annual dividend rate
0.06
Forward annual dividend yield
0.0488%
Trailing annual dividend rate
0.01
Trailing annual dividend yield
0.0122%
5-Year annual dividend yield
4.28%
Payout ratio
0.19
Dividend Date
6 Feb 2026
Ex-Dividend Date
30 Dec 2025
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2024
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.02%
Operating margin
0.03%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.08%
Income Statement
Revenue (ttm)
35.19B
Revenue per share (ttm)
76.03
Quarterly revenue growth (yoy)
0.05%
Gross profit (ttm)
3.72B
EBITDA
12.89B
Net income to common (ttm)
707.71M
Diluted EPS (ttm)
0.19
Quarterly earnings growth (yoy)
-0.38%
Balance Sheet
Total cash (mrq)
5.58B
Total cash per share (mrq)
12.01
Total debt (mrq)
7.38B
Total Debt/Equity (mrq)
65.73
Current ratio (mrq)
1.32%
Book value per share (mrq)
2.55
Cash Flow
Cash flow statement
676.2M
Levered free cash flow (LFCF)
-109.45M